Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Gastrointestinal Stromal Tumors. Found 10 abstracts

von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018 Jan 10;36(2):136-43.   PMCID: PMC6553810
Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016 Jul;2(7):922-8.   PMCID: PMC5472100
Vadakara J, von Mehren M. Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies. Hematol Oncol Clin North Am. 2013 Oct;27(5):905-20.   PMCID: Pmc3792495
von Mehren M, Widmer N. Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?. Cancer Treat Rev. 2011 Jun;37(4):291-9.   PMCID: not NIH funded
von Mehren M, Watson JC. Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?. Oncology (Williston Park). 2009 Jan;23(1):65-6.   PMCID: PMC 2861343
Belinsky MG, Rink L, Cai KQ, Ochs MF, Eisenberg B, Huang M, von Mehren M, Godwin AK. The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell cycle (Georgetown, Tex). 2008 Oct;7(19):2949-55.   PMCID: PMC2626174
Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92.   PMCID: PMC2448846
Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors . Clin Colorectal Cancer. 2006 Nov;6 Suppl 1:S7-17.
von Mehren M. Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategies. Current oncology reports. 2006 May;8(3):192-7.
Tarn C, Godwin AK. Molecular research directions in the management of gastrointestinal stromal tumors. Current treatment options in oncology. 2005 Nov;6(6):473-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors drug therapy Antineoplastic Agents Piperazines Pyrimidines Protein Kinase Inhibitors antagonists & inhibitors Proto-Oncogene Proteins c-kit genetics therapeutic use pharmacology metabolism Mutation Platelet-Derived Growth Factor alpha Receptor pathology Neoplasm Drug Resistance Pyrroles Gastrointestinal Neoplasms surgery Neoplasm Metastasis Neoplastic Gene Expression Regulation enzymology Protein-Tyrosine Kinases Platelet-Derived Growth Factor Receptors Signal Transduction ai [Antagonists & Inhibitors] Drug Monitoring Protein-Tyrosine Kinase Indoles Tumor Cell Line US Gov't Research Support-PHS Gene Silencing Treatment Outcome Tyrosine kinase inhibitors drug effects Gist dt [Drug Therapy] Somatomedins Proto-Oncogene Proteins c-ret Igf-1r methods Male ge [Genetics] Neoadjuvant Therapy me [Metabolism] Platelet-Derived Growth Factor) EC 2-7-1-112 (Receptors blood Succinate Dehydrogenase Adolescent Prognosis 0 (Piperazines) Patient Compliance DNA Mutational Analysis Proto-Oncogene Proteins c-akt Apoptosis Electron Transport Complex II Hsp90 EC 2-7-1-112 (Proto-Oncogene Proteins c-kit) classification 152459-95-5 (imatinib) Pdgfra DNA Methylation Germ-Line Mutation Adult Membrane Proteins Gene Amplification Genetic Promoter Regions Molecular Targeted Therapy Middle Aged Female pharmacokinetics EC 2-7-1-112 (Protein-Tyrosine Kinase) Small Interfering RNA 0 (Pyrimidines) Drug Delivery Systems Vascular Endothelial Growth Factor Receptors Disease-Free Survival SDH-deficient GIST secondary Kit Aged 0 (Protein Kinase Inhibitors) 0 (Antineoplastic Agents) IGF Type 1 Receptor trends Local Neoplasm Recurrence Mitogen-Activated Protein Kinase Kinases NIH Research Support-Extramural Drug Resistance Medical Oncology Clinical Trials as Topic tu [Therapeutic Use] Cell Proliferation Child
Last updated on Wednesday, February 05, 2020